Wednesday, July 8, 2026

pharma · Pain · Hyponatremia · CPIX

Cumberland Pharmaceuticals

Cumberland Pharmaceuticals is a pharma organization headquartered in Nashville, USA. It trades on NYSE under ticker CPIX. Primary therapeutic focus areas include Pain, Hyponatremia, Fever, Colonoscopy Preparation, Kidney

1600 W End Ave, #1300, Nashville, Tennessee 37203, US HQ
1999 Founded
128 Employees
Public company Type
CPIX · NYSE Ticker
Company details
Status
Public
HQ
1600 W End Ave, #1300, Nashville, Tennessee 37203, US
Founded
1999
Employees
128
Programs
53
Drugs
26
Patents
34
Clinical program

telavancin

Phase 1 · small molecule · Kidney Diseases

telavancin for Kidney Diseases is a Phase 1 program (small_molecule) at CUMBERLAND PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

← All CUMBERLAND PHARMACEUTICALS INC projects Phase 1 small molecule completed

Internal code 9809-CL-1407

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
CUMBERLAND PHARMACEUTICALS INC
Phase
Phase 1
Modality
small_molecule
Indication
Kidney Diseases
Status
completed
Trials
1